$BIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIO-RAD LABORATORIES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BIO-RAD LABORATORIES, INC.. Get notifications about new insider transactions in BIO-RAD LABORATORIES, INC. for free.
Page: < prev 1 2 3 4 5 6 7 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 1,800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 335.59 | 208 | 69,803 | 3,187 | 3.4 K to 3.2 K (-6.13 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 3,395 | 2.8 K to 3.4 K (+21.47 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 339.48 | 208 | 70,612 | 2,795 | 3 K to 2.8 K (-6.93 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 3,003 | 2.4 K to 3 K (+24.97 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 500 | 0 | 1,000 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 500 | 0 | 1,500 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 335.59 | 173 | 58,057 | 1,084 | 1.3 K to 1.1 K (-13.76 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 500 | 0 | 1,257 | 757 to 1.3 K (+66.05 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 339.48 | 173 | 58,730 | 757 | 930 to 757 (-18.60 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 500 | 0 | 930 | 430 to 930 (+116.28 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 7,800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 7,800 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 339.48 | 1,290 | 437,929 | 415,182 | 416.5 K to 415.2 K (-0.31 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 339.48 | 1,290 | 437,929 | 415,182 | 416.5 K to 415.2 K (-0.31 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,600 | 0 | 416,472 | 413.9 K to 416.5 K (+0.63 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,600 | 0 | 416,472 | 413.9 K to 416.5 K (+0.63 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 600 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 600 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 900 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 900 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 335.59 | 104 | 34,901 | 522 | 626 to 522 (-16.61 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 335.59 | 104 | 34,901 | 522 | 626 to 522 (-16.61 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 300 | 0 | 626 | 326 to 626 (+92.02 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 300 | 0 | 626 | 326 to 626 (+92.02 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 339.48 | 104 | 35,306 | 326 | 430 to 326 (-24.19 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 339.48 | 104 | 35,306 | 326 | 430 to 326 (-24.19 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 300 | 0 | 430 | 130 to 430 (+230.77 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 300 | 0 | 430 | 130 to 430 (+230.77 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 1,500 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 1,500 | |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 339.48 | 248 | 84,191 | 14,163 | 14.4 K to 14.2 K (-1.72 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 339.48 | 248 | 84,191 | 14,163 | 14.4 K to 14.2 K (-1.72 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 500 | 0 | 14,411 | 13.9 K to 14.4 K (+3.59 %) |
Sep 09 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 500 | 0 | 14,411 | 13.9 K to 14.4 K (+3.59 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 2,400 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 335.20 | 208 | 69,722 | 14,907 | 15.1 K to 14.9 K (-1.38 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 15,115 | 14.5 K to 15.1 K (+4.13 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 2,400 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | A | 333.34 | 2,784 | 928,019 | 2,784 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | A | 0.00 | 2,784 | 0 | 2,784 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 335.20 | 208 | 69,722 | 1,896 | 2.1 K to 1.9 K (-9.89 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 600 | 0 | 2,104 | 1.5 K to 2.1 K (+39.89 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 200 | 0 | 800 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | A | 0.00 | 774 | 0 | 774 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 335.20 | 70 | 23,464 | 130 | 200 to 130 (-35.00 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 200 | 0 | 200 | 0 to 200 |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 10,400 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | A | 333.34 | 11,597 | 3,865,744 | 11,597 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | A | 0.00 | 11,597 | 0 | 11,597 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 335.20 | 1,290 | 432,408 | 413,872 | 415.2 K to 413.9 K (-0.31 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,600 | 0 | 415,162 | 412.6 K to 415.2 K (+0.63 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 2,000 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | A | 333.34 | 1,856 | 618,679 | 1,856 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | A | 0.00 | 1,856 | 0 | 1,856 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 335.20 | 206 | 69,051 | 13,911 | 14.1 K to 13.9 K (-1.46 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 500 | 0 | 14,117 | 13.6 K to 14.1 K (+3.67 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 180 | 0 | 720 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | A | 0.00 | 774 | 0 | 774 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 335.20 | 63 | 21,118 | 4,143 | 4.2 K to 4.1 K (-1.50 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 180 | 0 | 4,206 | 4 K to 4.2 K (+4.47 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | M | 0.00 | 500 | 0 | 2,000 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | A | 333.34 | 2,320 | 773,349 | 2,320 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Option Exercise | A | 0.00 | 2,320 | 0 | 2,320 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Payment of Exercise | F | 335.20 | 173 | 57,990 | 430 | 603 to 430 (-28.69 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Buy | M | 0.00 | 500 | 0 | 603 | 103 to 603 (+485.44 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 2,400 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | A | 333.34 | 2,784 | 928,019 | 2,784 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | A | 0.00 | 2,784 | 0 | 2,784 | |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 335.20 | 208 | 69,722 | 2,403 | 2.6 K to 2.4 K (-7.97 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 600 | 0 | 2,611 | 2 K to 2.6 K (+29.84 %) |
Sep 05 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Sell | S | 333.08 | 1,089 | 362,723 | 2,011 | 3.1 K to 2 K (-35.13 %) |
Aug 14 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Sell | S | 320.00 | 310 | 99,200 | 103 | 413 to 103 (-75.06 %) |
Aug 14 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Sell | S | 320.00 | 310 | 99,200 | 103 | 413 to 103 (-75.06 %) |
Aug 14 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Sell | S | 320.00 | 325 | 104,000 | 3,100 | 3.4 K to 3.1 K (-9.49 %) |
Aug 14 2019 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Sell | S | 320.00 | 325 | 104,000 | 3,100 | 3.4 K to 3.1 K (-9.49 %) |
May 16 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Sell | S | 299.31 | 309 | 92,486 | 390 | 699 to 390 (-44.21 %) |
May 16 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Sell | S | 299.12 | 192 | 57,432 | 699 | 891 to 699 (-21.55 %) |
May 16 2019 | BIO | BIO-RAD LABORATORI ... | ERNST TIMOTHY S | EVP, General Counse ... | Sell | S | 290.00 | 345 | 100,050 | 891 | 1.2 K to 891 (-27.91 %) |
May 15 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 74.27 | 3,500 | 259,945 | 0 | |
May 15 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 290.63 | 1,803 | 524,002 | 13,617 | 15.4 K to 13.6 K (-11.69 %) |
May 15 2019 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 74.27 | 3,500 | 259,945 | 15,420 | 11.9 K to 15.4 K (+29.36 %) |
May 13 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 75.38 | 37,000 | 2,789,060 | 0 | |
May 13 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 296.28 | 22,833 | 6,764,961 | 275,809 | 298.6 K to 275.8 K (-7.65 %) |
May 13 2019 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 75.38 | 37,000 | 2,789,060 | 298,642 | 261.6 K to 298.6 K (+14.14 %) |
Apr 30 2019 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 299.24 | 5,000 | 1,496,200 | 5,000 | |
Apr 30 2019 | BIO | BIO-RAD LABORATORI ... | Last Andrew J. | EVP, Chief Operatin ... | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Apr 09 2019 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, CFO | Option Exercise | A | 309.84 | 3,500 | 1,084,440 | 3,500 | |
Apr 09 2019 | BIO | BIO-RAD LABORATORI ... | Daskal Ilan | EVP, CFO | Option Exercise | A | 0.00 | 3,500 | 0 | 3,500 | |
Dec 17 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Sell | S | 248.00 | 1,411 | 349,928 | 6,683 | 8.1 K to 6.7 K (-17.43 %) |
Dec 14 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Sell | S | 248.03 | 392 | 97,228 | 3,425 | 3.8 K to 3.4 K (-10.27 %) |
Dec 12 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Sell | S | 254.77 | 848 | 216,045 | 0 | 848 to 0 (-100.00 %) |
Dec 12 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 159.32 | 1,200 | 191,184 | 1,800 | |
Dec 12 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Sell | S | 255.00 | 1,200 | 306,000 | 1,504 | 2.7 K to 1.5 K (-44.38 %) |
Dec 12 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 159.32 | 1,200 | 191,184 | 2,704 | 1.5 K to 2.7 K (+79.79 %) |
Dec 12 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Sell | S | 254.00 | 1,176 | 298,704 | 1,504 | 2.7 K to 1.5 K (-43.88 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 400 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 308.37 | 347 | 107,004 | 2,680 | 3 K to 2.7 K (-11.46 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 1,000 | 0 | 3,027 | 2 K to 3 K (+49.33 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 3,200 | 0 | 6,400 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,600 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 308.37 | 2,877 | 887,180 | 261,588 | 264.5 K to 261.6 K (-1.09 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 5,800 | 0 | 264,465 | 258.7 K to 264.5 K (+2.24 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 500 | 0 | 1,000 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 160 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Payment of Exercise | F | 308.37 | 229 | 70,617 | 8,094 | 8.3 K to 8.1 K (-2.75 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Buy | M | 0.00 | 660 | 0 | 8,323 | 7.7 K to 8.3 K (+8.61 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 300 | 0 | 600 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 200 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 308.37 | 174 | 53,656 | 848 | 1 K to 848 (-17.03 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 500 | 0 | 1,022 | 522 to 1 K (+95.79 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 500 | 0 | 1,000 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 240 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 308.37 | 367 | 113,172 | 11,920 | 12.3 K to 11.9 K (-2.99 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 740 | 0 | 12,287 | 11.5 K to 12.3 K (+6.41 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 300 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 308.37 | 104 | 32,070 | 4,000 | 4.1 K to 4 K (-2.53 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 300 | 0 | 4,104 | 3.8 K to 4.1 K (+7.89 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Option Exercise | M | 0.00 | 700 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Payment of Exercise | F | 308.37 | 523 | 161,278 | 14,515 | 15 K to 14.5 K (-3.48 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | HERTIA JOHN | Executive Vice Pres ... | Buy | M | 0.00 | 1,300 | 0 | 15,038 | 13.7 K to 15 K (+9.46 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 600 | 0 | 1,200 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 376 | 0 | 0 | |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 308.37 | 339 | 104,537 | 3,817 | 4.2 K to 3.8 K (-8.16 %) |
Sep 13 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 976 | 0 | 4,156 | 3.2 K to 4.2 K (+30.69 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,000 | |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Payment of Exercise | F | 308.00 | 992 | 305,536 | 258,665 | 259.7 K to 258.7 K (-0.38 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | SCHWARTZ NORMAN D | Chairman, President ... | Buy | M | 0.00 | 2,000 | 0 | 259,657 | 257.7 K to 259.7 K (+0.78 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Option Exercise | M | 0.00 | 389 | 0 | 389 | |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Payment of Exercise | F | 308.00 | 135 | 41,580 | 3,180 | 3.3 K to 3.2 K (-4.07 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | Crowley Michael | EVP, GBL Commercial ... | Buy | M | 0.00 | 389 | 0 | 3,315 | 2.9 K to 3.3 K (+13.29 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Option Exercise | M | 0.00 | 400 | 0 | 400 | |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Payment of Exercise | F | 308.00 | 139 | 42,812 | 2,027 | 2.2 K to 2 K (-6.42 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | TUMOLO ANNETTE | Executive Vice Pres ... | Buy | M | 0.00 | 400 | 0 | 2,166 | 1.8 K to 2.2 K (+22.65 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Option Exercise | M | 0.00 | 400 | 0 | 400 | |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Payment of Exercise | F | 308.00 | 139 | 42,812 | 7,663 | 7.8 K to 7.7 K (-1.78 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | TSINGOS CHRISTINE A | EVP and CFO | Buy | M | 0.00 | 400 | 0 | 7,802 | 7.4 K to 7.8 K (+5.40 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Option Exercise | M | 0.00 | 200 | 0 | 200 | |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Payment of Exercise | F | 308.00 | 70 | 21,560 | 522 | 592 to 522 (-11.82 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | STARK JAMES R | VP, Corporate Contr ... | Buy | M | 0.00 | 200 | 0 | 592 | 392 to 592 (+51.02 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Option Exercise | M | 0.00 | 400 | 0 | 400 | |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Payment of Exercise | F | 308.00 | 199 | 61,292 | 11,547 | 11.7 K to 11.5 K (-1.69 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | Magni Giovanni | EVP, Chief Strategy ... | Buy | M | 0.00 | 400 | 0 | 11,746 | 11.3 K to 11.7 K (+3.53 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Option Exercise | M | 0.00 | 150 | 0 | 150 | |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Payment of Exercise | F | 308.00 | 52 | 16,016 | 3,804 | 3.9 K to 3.8 K (-1.35 %) |
Sep 12 2018 | BIO | BIO-RAD LABORATORI ... | HUTTON RONALD W | Vice President and ... | Buy | M | 0.00 | 150 | 0 | 3,856 | 3.7 K to 3.9 K (+4.05 %) |